CFO Fenimore sells 5,680 shares (99.6% of holdings) for $6.8M, reducing stake to 25 shares
Christopher R. Fenimore, SVP Finance & CFO, executed 10 separate sales on 2024-08-28 totaling 5,680 shares for $6,846,262.22, reducing his holdings from 5,705 shares to just 25 shares—a near-complete exit of his position. The blended average sale price of $1,205.33 occurred within the 52-week range ($775.18–$1,201.76) and 1.9% below the 52-week high. At his prior REGN sales on 2024-02-09, 0 of 5 prior sells were well-timed at the 90-day mark, with all five resulting in modest positive 90-day returns (ranging 1.4%–1.8%), meaning the stock rose after his prior exits. The scale and breadth of this liquidation—virtually eliminating executive ownership—deserves scrutiny, particularly given Regeneron's solid near-term fundamentals (FY revenue growth +7.8%, P/E 25.63) and the stock's strong recent momentum (+9.4% in 30 days, +20.3% in 90 days). Investors should monitor whether this represents a strategic shift in the CFO's equity commitment or reflects other considerations.